Newsletter - September 2020
FEATURED CONTENT: The New Virtual Launch
Last week, former Global Head of Digital for Bayer, Eugene Borukhovich joined DHC Co-Founder Mark Bard and experts from OptimizeRx, Chris DiCostanzo and Rebecca Love, along with Mary Anne Greeneberg of Diligent Health Solutions, to discuss innovations in new medication launches. This group discussed innovative and best-in-practice approaches to new drug launches that explore the art, science, and psychology to treatment and medication adherence.
ADDITIONAL INSIGHTS FROM DHC PARTNERS
Via meltmedia →
Traditionally, a launch started with a print piece. Once you nailed down your messaging in that initial piece, you’d move into other channels and derive the messaging for your website or sales presentation or email. In this scenario, your print piece was out the door day 1 and everything else followed. “Digital-first upends that process,” explains Ron Barry, co-founder and vice president of Business Development at digital agency meltmedia.
Read More →
Via Instep Health →
Read about the pharma marketers who saw successful campaign results during stay at home orders,and how important it is to adjust campaign expectations without changing the way results are measured. All this and more in the latest white paper from InStep Health: Achieving Results Amid a Pandemic.
Access Whitepaper →
Via WEGO Health →
WEGO Health recently asked 125 Patient Leaders to weigh in with their perspectives on digital health adoption in their condition communities. The COVID-19 crisis has significantly accelerated the shift toward digital, so WEGO Health wanted to understand which types of technologies and digital therapeutics patients value and trust most, and which they want to see more of.
Learn More →
Please Note New Date: September 30 / October 1, 12:00 - 1:30 eastern
The DHC, with host Novartis, is converted the originally scheduled East Coast Summit to a virtual event. The September 30 & October 1 online summit will feature research highlights, case studies, thought leader POVs and panel discussions with key stakeholders addressing the opportunities and challenges of "the new normal".
View Speakers, Agenda, and Register Here →